Template:Ganglioneuroma: Difference between revisions

Jump to navigation Jump to search
(Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''G...")
 
No edit summary
 
(4 intermediate revisions by 3 users not shown)
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma (patient information)|Patient Info]]
[[Ganglioneuroma (patient information)|Patient Information]]
|-  
|-  
!
!
Line 29: Line 29:
!
!
[[Ganglioneuroma historical perspective|Historical Perspective]]
[[Ganglioneuroma historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
!
[[Ganglioneuroma classification|Classification]]
|-  
|-  
!
!
Line 40: Line 46:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma epidemiology and demographics|Epidemiology & Demographics]]
[[Ganglioneuroma causes|Causes]]
|-  
|-  
!
!
Line 46: Line 52:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma risk factors|Risk Factors]]
[[Ganglioneuroma differential diagnosis|Differentiating Ganglioneuroma from other Diseases]]
|-  
|-  
!
!
Line 52: Line 58:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma screening|Screening]]
[[Ganglioneuroma epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 58: Line 64:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma causes|Causes of Ganglioneuroma]]
[[Ganglioneuroma risk factors|Risk Factors]]
|-  
|-  
!
!
Line 64: Line 70:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma differential diagnosis|Differentiating Ganglioneuroma from other Diseases]]
[[Ganglioneuroma screening|Screening]]
|-  
|-  
!
!
Line 70: Line 76:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Ganglioneuroma natural history|Natural History, Complications & Prognosis]]
[[Ganglioneuroma natural history|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 82: Line 88:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Ganglioneuroma history and symptoms|History & Symptoms]]
[[Ganglioneuroma staging|Staging]]
|-  
|-  
!
!
Line 88: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Ganglioneuroma physical examination|Physical Examination]]
[[Ganglioneuroma history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 94: Line 100:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Ganglioneuroma laboratory tests|Lab Tests]]
[[Ganglioneuroma physical examination|Physical Examination]]
|-  
|-  
!
!
Line 100: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Ganglioneuroma electrocardiogram|Electrocardiogram]]
[[Ganglioneuroma laboratory tests|Laboratory Findings]]
|-  
|-  
!
!
Line 106: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Ganglioneuroma chest x ray|Chest X Ray]]
[[Ganglioneuroma x ray|X Ray]]
|-  
|-  
!
!
Line 124: Line 130:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Ganglioneuroma echocardiography or ultrasound|Echocardiography or Ultrasound]]
[[Ganglioneuroma ultrasound|Ultrasound]]
|-  
|-  
!
!
Line 160: Line 166:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Ganglioneuroma primary prevention|Primary Prevention]]
[[Ganglioneuroma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 166: Line 172:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Ganglioneuroma secondary prevention|Secondary Prevention]]
[[Ganglioneuroma future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  


|- bgcolor="PaleTurquoise"
|- bgcolor="CadetBlue"
!
!
[[Ganglioneuroma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
Case Studies
|-  
|-  
!  
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Ganglioneuroma future or investigational therapies|Future or Investigational Therapies]]
[[Ganglioneuroma case study one|Case #1]]
|-  
|-  
!  
!


|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "

Latest revision as of 15:50, 11 September 2015